Angelini Pharma acquires Catalyst Pharmaceuticals

Angelini Pharma agreed to acquire Catalyst Pharmaceuticals. Reported deal value: Undisclosed. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Coral Gables, Florida, United States.

This page summarizes publicly available information about the transaction as of 2026-04-27. Figures and status may change as filings and press coverage update.

Customer Support Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world For Customers Advertising Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world For Customers April 27, 2026 at 4: 04 PM UTC Updated on April 27, 2026 at 4:37 PM UTC Bookmark Save Italian drugmaker Angelini Pharma is exploring...